FENNEC PHARMACEUTICALS INC. — Director's Dealing 2019

Sep 13, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2019-09-09

Reporting Person: Goel Shubh (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.74	2029-09-09	Common shares (175000)		Direct

Footnotes

F1: On September 9, 2019, Shubh Goel was granted an incentive stock option to purchase 175,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan.

F2: 1/3 of the shares subject to this option shall vest and may be exercised as of September 9, 2020 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of September 9, 2022 and thereafter, 100% of the total number of shares subject to this option shall be vested.